APA (7th ed.) Citation

Raykov, Z. Z., Grekova, S., & Giese, N. (2014). Myo-inositol trispyrophosphate-mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy. International journal of cancer, 134(11), . https://doi.org/10.1002/ijc.28597

Chicago Style (17th ed.) Citation

Raykov, Zahari Zahariev, Svitlana Grekova, and Nathalia Giese. "Myo-inositol Trispyrophosphate-mediated Hypoxia Reversion Controls Pancreatic Cancer in Rodents and Enhances Gemcitabine Efficacy." International Journal of Cancer 134, no. 11 (2014). https://doi.org/10.1002/ijc.28597.

MLA (9th ed.) Citation

Raykov, Zahari Zahariev, et al. "Myo-inositol Trispyrophosphate-mediated Hypoxia Reversion Controls Pancreatic Cancer in Rodents and Enhances Gemcitabine Efficacy." International Journal of Cancer, vol. 134, no. 11, 2014, https://doi.org/10.1002/ijc.28597.